Boundless Bio, Inc. (BOLD)

Boundless Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	40.21	23.71	10.95	34.29
Short-Term Investments	126.92	97.05	55.77	38.74
Cash & Short-Term Investments	167.14	120.75	66.72	73.03
Cash Growth	25.92%	80.99%	-8.65%	-
Prepaid Expenses	2.81	3.15	1.32	1.54
Other Current Assets	0.5	0.3	-	-
Total Current Assets	170.45	124.2	68.04	74.57
Property, Plant & Equipment	4.07	5.08	7.73	3.1
Long-Term Investments	-	-	-	34.99
Other Long-Term Assets	0.58	0.62	1.07	1.07
Total Assets	175.09	129.89	76.83	113.72
Accounts Payable	2.54	2.22	1.4	1.08
Accrued Expenses	7.35	4.94	3.9	2.08
Current Portion of Leases	0.12	2.2	2.34	0.38
Other Current Liabilities	-	-	0.09	0.34
Total Current Liabilities	10.01	9.36	7.73	3.87
Long-Term Leases	-	-	2.85	-
Other Long-Term Liabilities	-	-	0.01	0.1
Total Liabilities	10.01	9.36	10.58	3.96
Common Stock	0	0	0	0
Additional Paid-In Capital	349.87	8.99	5.38	2.76
Retained Earnings	-185.02	-136.11	-86.68	-40.77
Comprehensive Income & Other	0.24	0.04	-0.4	-0.18
Total Common Equity	165.08	-127.08	-81.7	-38.19
Shareholders' Equity	165.08	120.54	66.25	109.76
Total Liabilities & Equity	175.09	129.89	76.83	113.72
Total Debt	0.12	2.2	5.18	0.38
Net Cash (Debt)	167.01	118.56	61.53	72.66
Net Cash Growth	30.12%	92.67%	-15.31%	-
Net Cash Per Share	14.26	97.49	56.05	84.43
Filing Date Shares Outstanding	22.3	1.25	1.13	0.86
Total Common Shares Outstanding	22.25	1.25	1.13	0.86
Working Capital	160.44	114.85	60.31	70.7
Book Value Per Share	7.42	-102.02	-71.99	-44.38
Tangible Book Value	165.08	-127.08	-81.7	-38.19
Tangible Book Value Per Share	7.42	-102.02	-71.99	-44.38
Machinery	6.78	5.25	4.69	3.7
Leasehold Improvements	0.7	0.05	0.05	0.2

Source: S&P Capital IQ. Standard template. Financial Sources.